美國、EU各國的實驗室資訊管理系統 (LIMS) 市場 (2020年):轉移到混合雲端服務促進成長
Transition to Hybrid Cloud Services to Trigger the Growth of Laboratory Information Management Systems in the United States and European Union, 2020
本報告提供美國及EU各國的實驗室資訊管理系統 (LIMS) 市場的趨勢相關分析，LIMS概要，及市場基本結構與主要促進、阻礙因素，各地區市場規模趨勢預測 (2026年)，各終端用戶 (製藥，生物銀行，臨床診斷，政府，教育、研究機關)、各產品種類 (複雜型用戶端，精簡型用戶端，雲端本機)的詳細趨勢，近來的技術、產業趨勢，今後的成長機會與課題等調查。
Thriving Demand for Biorepositories and Maturity of the Biobanking Industry to Unlock New Growth Opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU laboratory information management system (LIMS) industry, highlighting the key growth opportunities, market revenue forecast, and trends that will play an important role in industry growth.
The US and EU LIMS market covered in this study is segmented by end user (pharmaceutical, biobanks, clinical diagnostics, government, and academic institutions) and by product type (thick-client, thin-client, and cloud-native). The market forecast is provided through 2026, capturing the interesting trends, developments and end-user dynamics that will influence the growth of industry participants.
This research service identifies the largest revenue-generating as well as the fastest-growing end- user segment in the industry. The impact of the COVID-19 pandemic on market revenue potential for both the United States and the European Union are also detailed. Strategic imperatives needed to consolidate the customer base as well as improve market penetration are clearly outlined. The study also provides comprehensive insights on the complex dynamics in the LIMS industry with regard to pricing trends, production adoption trends, and the key industry participants. It also profiles the competitive environment in the LIMS industry, outlining the strategy and capabilities of the top competitors.
With this research service, Frost & Sullivan's Transformational Health group offers insightful analysis in the form of key growth opportunities that revolve around the use of artificial intelligence in LIMS for quality assurance and quality control of manufacturing, client expectations in the biobanking industry, and the adoption of hybrid cloud for flexible and agile data management.